Newsroom
October 3, 2024
Jessica Treviño Jones, MD, associate professor in the Division of Hematology-Oncology at UT Health San Antonio, and founder and director of the Cancer Risk Reduction and Education Clinic at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed in this news segment. Listen Now
October 3, 2024
Jessica Treviño Jones, MD, associate professor in the Division of Hematology-Oncology at UT Health San Antonio, and founder and director of the Cancer Risk Reduction and Education Clinic at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed in this news segment. Listen Now
October 3, 2024
Jessica Treviño Jones, MD, associate professor in the Division of Hematology-Oncology at UT Health San Antonio, and founder and director of the Cancer Risk Reduction and Education Clinic at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed in this news segment. Listen Now
October 3, 2024
Jessica Treviño Jones, MD, associate professor in the Division of Hematology-Oncology at UT Health San Antonio, and founder and director of the Cancer Risk Reduction and Education Clinic at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed in this news segment. Listen Now
October 3, 2024
Jessica Treviño Jones, MD, associate professor in the Division of Hematology-Oncology at UT Health San Antonio, and founder and director of the Cancer Risk Reduction and Education Clinic at Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, was interviewed in this news segment. Listen Now
October 3, 2024
Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]
